Cue Health

Carebook reports record revenue and the first quarter of positive adjusted EBITDA, while Cue Health sees large net and adjusted EBITDA losses.

The company was also the first to receive emergency use authorization for its home COVID-19 test in 2021.

In a letter to employees, CEO Ayub Khattak said the diagnostics company's new initiatives are "progressing well but are still early in terms of revenue generation."

The home diagnostics company also cut 170 manufacturing jobs in the summer.

FundamentalVR adds four women to its executive team, Eleanor Health announces three new hires, and Cue Health appoints two members to its board of directors.  

Komodo Health appointed Lauren Stahl as vice president and head of sales, while Woebot Health and Cue Health hired chief commercial officers.

Cue said it made the decision due to larger economic challenges and the federal government's recent move to divert funding from COVID-19 tests.

Also: Baby tech company Owlet and diagnostics-focused Cue Health plan on submitting for regulatory clearances this year.

Also: Medicare Advantage insurer Zing Health partners with Papa. Verily and biopharma-company Sosei Heptares announce a research collaboration. Pharma-focused accelerator PharmStars’ next cohort will focus on neurological diseases.

After another rough year for the healthcare system, startups are using the growth of virtual care to manage chronic conditions and expand primary care.